Live feed
Filing
SC 13G
SC 13G0001683168-21-003803·Organicell Regenerative Medicine, Inc.
Schedule 13G ownership disclosure
BIOTECH PRODUCT SERVICES & RES
Security class unavailable · CUSIP: 09074L105
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 77,500,000
- Percent of class
- 7.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001683168-21-003803
- Form type
- SC 13G
- Filer
- Organicell Regenerative Medicine, Inc.
- CIK
- CIK 1557376
- Filed
- Aug 20, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership